Nevertheless, another nonsteroidal MRB, finerenone has been shown to be effective in attenuating diastolic dysfunction in chronic kidney diseases mice [39], transgenic mice with cardiac-specific overexpression of Rac1 [40], and deoxycorticosterone acetate-/salt-challenged rats [41]. The gene discussed is RAC1; the disease is chronic kidney disease.